News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Her2 Positive Breast Cancer
December 16, 2025
Enhertu (Trastuzumab Deruxtecan) Treatment of HER2+ Breast Cancer
Charles H. Weaver, MD
April 10, 2025
Tissue Agnostic – Genomic Based Treatment – A Paradigm Shift in Cancer Treatment
Charles H. Weaver, MD
March 1, 2022
Elacestrant Hormone Therapy for Advanced Breast Cancer
Charles H. Weaver, MD
March 23, 2020
Perjeta Treatment of HER2 positive Breast Cancer
Charles H. Weaver, MD
March 7, 2020
Hispanic Women Speak Out About Breast Cancer
Charles H. Weaver, MD
June 12, 2019
Herceptin Treatment of HER2-positive Advanced-Metastatic Breast Cancer
Charles H. Weaver, MD
July 1, 2018
She Wrote the Book… on Advanced Breast Cancer
Charles H. Weaver, MD
May 1, 2018
Strength in Numbers
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
